ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,063.20
      0.01%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,413.79
      -0.10%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Brazil
      5. BOV
      6. Idexx Laboratories Inc (I1DX34)

      7. Idexx Laboratories Inc (I1DX34) Financials

      I1DX34 Idexx Laboratories Inc

      517.70
      0.03 (0.01%)
      May 31 2024 - Closed
      Delayed by 15 minutes

      Idexx Laboratories Financial Summary

      The current I1DX34 market cap is 43B. The company's latest EPS is USD 10.1749 and P/E is 48.84.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 900.2M943.63M915.53M901.6M964.1M
      Operating Income 280.4M296.14M275.28M246.4M298.96M
      Net Income 214.05M224.24M212.23M194.52M235.58M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 2.41B2.71B3.22B3.37B3.66B
      Operating Income 552.85M694.52M932.03M898.77M1.1B
      Net Income 427.72M581.78M744.85M679.09M845.04M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.81B2.87B3.09B3.26B3.35B
      Total Liabilities 1.97B1.78B1.79B1.78B1.78B
      Total Equity 841.1M1.09B1.3B1.48B1.57B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.83B2.29B2.44B2.75B3.26B
      Total Liabilities 1.65B1.66B1.75B2.14B1.78B
      Total Equity 177.83M632.8M689.99M608.74M1.48B

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 183.91M384.23M656.66M906.51M198.59M
      Investing -39.51M-66.98M-94.82M-125.25M-106.94M
      Financing -146.08M-297.11M-340.15M-442M-144.07M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 459.16M648.06M755.55M542.98M906.51M
      Investing -205.53M-109.38M-292.97M-195.35M-125.25M
      Financing -286.41M-248.42M-697.41M-370.94M-442M

      Stats and Ratios

      Market Cap 43B
      Price to Earnings Ratio 48.84
      Price to Sales Ratio 11.27
      Price to Cash Ratio 90.92
      Price to Book Ratio 27.8
      Dividend Yield -

      Share Statistics

      Shares Outstanding 83.05M
      Average Volume (1 week) 21
      Average Volume (1 Month) 561
      52 Week Change 9.73%
      52 Week High 575.20
      52 Week Low 436.04
      Spread (Intraday) 3.12 (0.6%)

      Company Info

      Company Name Idexx Laboratories Inc
      Address corporation trust center 1209
      wilmington, delaware 19801
      Website https://www.idexx.com
      Industry in vitro,in vivo diagnostics (2835)